Lung transplantation for obstructive lung diseases

Seminars in Respiratory and Critical Care Medicine

Volumn 34, Issue 3, 2013, Pages 288-296

  Shah, Rupalj ^a   Kotloff, Robertm ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

1 antitrypsin deficiency; chronic obstructive pulmonary disease; Langerhans cell histiocytosis; lung transplantation; lymphangioleiomyomatosis

Indexed keywords

AZATHIOPRINE; RAPAMYCIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ANGIOMYOLIPOMA; ARTICLE; BODY MASS; BRONCHIOLITIS OBLITERANS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COR PULMONALE; ENZYME REPLACEMENT; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GAS EXCHANGE; GRAFT RECIPIENT; HUMAN; HYPERCAPNIA; HYPOXEMIA; IMMUNOSURVEILLANCE; INTERSTITIAL LUNG DISEASE; LANGERHANS CELL HISTIOCYTOSIS; LONG TERM SURVIVAL; LUNG ARTERY PRESSURE; LUNG CANCER; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG LAVAGE; LUNG RESECTION; LUNG TRANSPLANTATION; LYMPHANGIOLEIOMYOMATOSIS; NUTRITIONAL STATUS; OXYGEN CONSUMPTION; PHRENIC NERVE; PHYSICAL ACTIVITY; PLEURODESIS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RECURRENT LARYNGEAL NERVE; RESIDUAL VOLUME; SHORT TERM SURVIVAL; SMOKING; SUPPLEMENTATION; TENSION PNEUMOTHORAX; TUBEROUS SCLEROSIS;

ALPHA 1-ANTITRYPSIN DEFICIENCY; EMPHYSEMA; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LUNG DISEASES, OBSTRUCTIVE; LUNG TRANSPLANTATION; LYMPHANGIOLEIOMYOMATOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84879928838     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0033-1348468     Document Type: Article

References (73)

1. Christie J. D., Edwards L. B., Kucheryavaya A. Y., et al. International Society of Heart and Lung Transplantation The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant: 2012; 31 10 1073 1086
2. Vestbo J., Edwards L. D., Scanlon P. D., et al. ECLIPSE Investigators Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med: 2011; 365 13 1184 1192
3. Nishimura M., Makita H., Nagai K., et al. Hokkaido COPD Cohort Study Investigators Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med: 2012; 185 1 44 52
4. Martinez F. J., Kotloff R. Prognostication in chronic obstructive pulmonary disease: implications for lung transplantation. Semin Respir Crit Care Med: 2001; 22 5 489 498
5. Traver G. A., Cline M. G., Burrows B. Predictors of mortality in chronic obstructive pulmonary disease: a 15-year follow-up study. Am Rev Respir Dis: 1979; 119 6 895 902
6. Celli B. R., Cote C. G., Marin J. M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med: 2004; 350 10 1005 1012
7. Martinez F. J., Han M. K., Andrei A. C., et al. National Emphysema Treatment Trial Research Group Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med: 2008; 178 5 491 499
8. Orens J. B., Estenne M., Arcasoy S., et al. Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant: 2006; 25 7 745 755
9. Egan T. M., Kotloff R. M. Pro/Con debate: lung allocation should be based on medical urgency and transplant survival and not on waiting time. Chest: 2005; 128 1 407 415
10. Yusen R. D., Shearon T. H., Qian Y., et al. Lung transplantation in the United States, 1999-2008. Am J Transplant: 2010; 10 4 Pt 2 1047 1068
11. McCurry K. R., Shearon T. H., Edwards L. B., et al. Lung transplantation in the United States, 1998-2007. Am J Transplant: 2009; 9 4 Pt 2 942 958
12. Fishman A., Martinez F., Naunheim K., et al. National Emphysema Treatment Trial Research Group A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med: 2003; 348 21 2059 2073
13. Meyers B. F., Yusen R. D., Guthrie T. J., et al. Outcome of bilateral lung volume reduction in patients with emphysema potentially eligible for lung transplantation. J Thorac Cardiovasc Surg: 2001; 122 1 10 17
14. Senbaklavaci O., Wisser W., Ozpeker C., et al. Successful lung volume reduction surgery brings patients into better condition for later lung transplantation. Eur J Cardiothorac Surg: 2002; 22 3 363 367
15. Burns K. E., Keenan R. J., Grgurich W. F., Manzetti J. D., Zenati M. A. Outcomes of lung volume reduction surgery followed by lung transplantation: a matched cohort study. Ann Thorac Surg: 2002; 73 5 1587 1593
16. Bavaria J. E., Pochettino A., Kotloff R. M., et al. Effect of volume reduction on lung transplant timing and selection for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg: 1998; 115 1 9 17, discussion 17-18
17. Stevens P. M., Johnson P. C., Bell R. L., Beall A. C. Jr, Jenkins D. E. Regional ventilation and perfusion after lung transplantation in patients with emphysema. N Engl J Med: 1970; 282 5 245 249
18. Levine S. M., Anzueto A., Peters J. I., et al. Medium term functional results of single-lung transplantation for endstage obstructive lung disease. Am J Respir Crit Care Med: 1994; 150 2 398 402
19. Mal H., Andreassian B., Pamela F., et al. Unilateral lung transplantation in end-stage pulmonary emphysema. Am Rev Respir Dis: 1989; 140 3 797 802
20. Bavaria J. E., Kotloff R., Palevsky H., et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg: 1997; 113 3 520 527, discussion 528
21. Pochettino A., Kotloff R. M., Rosengard B. R., et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate-term results. Ann Thorac Surg: 2000; 70 6 1813 1818, discussion 1818-1819
22. Sundaresan R. S., Shiraishi Y., Trulock E. P., et al. Single or bilateral lung transplantation for emphysema? J Thorac Cardiovasc Surg: 1996; 112 6 1485 1494, discussion 1494-1495
23. Meyer D. M., Bennett L. E., Novick R. J., Hosenpud J. D. Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant: 2001; 20 9 935 941
24. Thabut G., Christie J. D., Ravaud P., et al. Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet: 2008; 371 9614 744 751
25. Gaissert H. A., Trulock E. P., Cooper J. D., Sundaresan R. S., Patterson G. A. Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg: 1996; 111 2 296 306, discussion 306-307
26. Bossenbroek L., ten Hacken N. H., van der Bij W., Verschuuren E. A., Koëter G. H., de Greef M. H. Cross-sectional assessment of daily physical activity in chronic obstructive pulmonary disease lung transplant patients. J Heart Lung Transplant: 2009; 28 2 149 155
27. Gerbase M. W., Spiliopoulos A., Rochat T., Archinard M., Nicod L. P. Health-related quality of life following single or bilateral lung transplantation: a 7-year comparison to functional outcome. Chest: 2005; 128 3 1371 1378
28. Levy R. D., Ernst P., Levine S. M., et al. Exercise performance after lung transplantation. J Heart Lung Transplant: 1993; 12 1 Pt 1 27 33
29. Williams T. J., Patterson G. A., McClean P. A., Zamel N., Maurer J. R. Maximal exercise testing in single and double lung transplant recipients. Am Rev Respir Dis: 1992; 145 1 101 105
30. Hadjiliadis D., Davis R. D., Palmer S. M. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients? Chest: 2002; 122 4 1168 1175
31. Burton C. M., Iversen M., Mortensen J., et al. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder? J Heart Lung Transplant: 2007; 26 11 1127 1134
32. Munson J. C., Christie J. D., Halpern S. D. The societal impact of single versus bilateral lung transplantation for chronic obstructive pulmonary disease. Am J Respir Crit Care Med: 2011; 184 11 1282 1288
33. Arcasoy S. M., Hersh C., Christie J. D., et al. Bronchogenic carcinoma complicating lung transplantation. J Heart Lung Transplant: 2001; 20 10 1044 1053
34. de Perrot M., Chernenko S., Waddell T. K., et al. Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease. J Clin Oncol: 2004; 22 21 4351 4356
35. Dickson R. P., Davis R. D., Rea J. B., Palmer S. M. High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant: 2006; 25 11 1297 1301
36. Minai O. A., Shah S., Mazzone P., et al. Bronchogenic carcinoma after lung transplantation: characteristics and outcomes. J Thorac Oncol: 2008; 3 12 1404 1409
37. Weill D., Torres F., Hodges T. N., Olmos J. J., Zamora M. R. Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema. J Heart Lung Transplant: 1999; 18 11 1080 1087
38. Yonan N. A., el-Gamel A., Egan J., Kakadellis J., Rahman A., Deiraniya A. K. Single lung transplantation for emphysema: predictors for native lung hyperinflation. J Heart Lung Transplant: 1998; 17 2 192 201
39. Gavazzeni V., Iapichino G., Mascheroni D., et al. Prolonged independent lung respiratory treatment after single lung transplantation in pulmonary emphysema. Chest: 1993; 103 1 96 100
40. Reece T. B., Mitchell J. D., Zamora M. R., et al. Native lung volume reduction surgery relieves functional graft compression after single-lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg: 2008; 135 4 931 937
41. Anderson M. B., Kriett J. M., Kapelanski D. P., Perricone A., Smith C. M., Jamieson S. W. Volume reduction surgery in the native lung after single lung transplantation for emphysema. J Heart Lung Transplant: 1997; 16 7 752 757
42. Venuta F., De Giacomo T., Rendina E. A., et al. Thoracoscopic volume reduction of the native lung after single lung transplantation for emphysema. Am J Respir Crit Care Med: 1997; 156 292 293
43. Crespo M. M., Johnson B. A., McCurry K. R., Landreneau R. J., Sciurba F. C. Use of endobronchial valves for native lung hyperinflation associated with respiratory failure in a single-lung transplant recipient for emphysema. Chest: 2007; 131 1 214 216
44. Hosenpud J. D., Bennett L. E., Keck B. M., Edwards E. B., Novick R. J. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet: 1998; 351 9095 24 27
45. De Meester J., Smits J. M., Persijn G. G., Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant: 2001; 20 5 518 524
46. Charman S. C., Sharples L. D., McNeil K. D., Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant: 2002; 21 2 226 232
47. Stavem K., Bjortuft O., Borgan O., Geiran O., Boe J. Lung transplantation in patients with chronic obstructive pulmonary disease in a national cohort is without obvious survival benefit. J Heart Lung Transplant: 2006; 25 1 75 84
48. Titman A., Rogers C. A., Bonser R. S., Banner N. R., Sharples L. D. Disease-specific survival benefit of lung transplantation in adults: a national cohort study. Am J Transplant: 2009; 9 7 1640 1649
49. Thabut G., Ravaud P., Christie J., et al. Determinants of the survival benefit of lung transplantation in COPD patients. Am J Respir Crit Care Med: 2008; 177 10 1156 1163
50. Lahzami S., Bridevaux P. O., Soccal P. M., et al. Survival impact of lung transplantation for COPD. Eur Respir J: 2010; 36 1 74 80
51. King M. B., Campbell E. J., Gray B. H., Hertz M. I. The proteinase-antiproteinase balance in alpha-1-proteinase inhibitor-deficient lung transplant recipients. Am J Respir Crit Care Med: 1994; 149 4 Pt 1 966 971
52. Meyer K. C., Nunley D. R., Dauber J. H., et al. Neutrophils, unopposed neutrophil elastase, and alpha1-antiprotease defenses following human lung transplantation. Am J Respir Crit Care Med: 2001; 164 1 97 102
53. Mal H., Guignabert C., Thabut G., et al. Recurrence of pulmonary emphysema in an alpha-1 proteinase inhibitor-deficient lung transplant recipient. Am J Respir Crit Care Med: 2004; 170 7 811 814
54. Strange C., Stoller J. K., Sandhaus R. A., Dickson R., Turino G. Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration: 2006; 73 2 185 190
55. Oprescu N., McCormack F. X., Byrnes S., Kinder B. W. Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry. Lung: 2013; 191 1 35 42
56. Benden C., Rea F., Behr J., et al. Lung transplantation for lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant: 2009; 28 1 1 7
57. Kpodonu J., Massad M. G., Chaer R. A., et al. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. J Heart Lung Transplant: 2005; 24 9 1247 1253
58. Boehler A., Speich R., Russi E. W., Weder W. Lung transplantation for lymphangioleiomyomatosis. N Engl J Med: 1996; 335 17 1275 1280
59. Pechet T. T., Meyers B. F., Guthrie T. J., et al. Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant: 2004; 23 3 301 308
60. Reynaud-Gaubert M., Mornex J. F., Mal H., et al. Lung transplantation for lymphangioleiomyomatosis: the French experience. Transplantation: 2008; 86 4 515 520
61. Machuca T. N., Losso M. J., Camargo S. M., et al. Lung transplantation for lymphangioleiomyomatosis: single-center Brazilian experience with no chylothorax. Transplant Proc: 2011; 43 1 236 238
62. Groetzner J., Kur F., Spelsberg F., et al. Munich Lung Transplant Group Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression. J Heart Lung Transplant: 2004; 23 5 632 638
63. King-Biggs M. B., Dunitz J. M., Park S. J., Kay Savik S., Hertz M. I. Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. Transplantation: 2003; 75 9 1437 1443
64. Bittmann I., Rolf B., Amann G., Löhrs U. Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. Hum Pathol: 2003; 34 1 95 98
65. Karbowniczek M., Astrinidis A., Balsara B. R., et al. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med: 2003; 167 7 976 982
66. Ohara T., Oto T., Miyoshi K., et al. Sirolimus ameliorated post lung transplant chylothorax in lymphangioleiomyomatosis. Ann Thorac Surg: 2008; 86 6 e7 e8
67. Chen F., Bando T., Fukuse T., et al. Recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation. Transplant Proc: 2006; 38 9 3151 3153
68. Shigemura N., Kawamura T., Minami M., et al. Successful factor XIII administration for persistent chylothorax after lung transplantation for lymphangioleiomyomatosis. Ann Thorac Surg: 2009; 88 3 1003 1006
69. Bhorade S., Ahya V. N., Baz M. A., et al. Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. Am J Respir Crit Care Med: 2011; 183 3 379 387
70. Vassallo R., Ryu J. H., Colby T. V., Hartman T., Limper A. H. Pulmonary Langerhans-cell histiocytosis. N Engl J Med: 2000; 342 26 1969 1978
71. Dauriat G., Mal H., Thabut G., et al. Lung transplantation for pulmonary Langerhans cell histiocytosis: a multicenter analysis. Transplantation: 2006; 81 5 746 750
72. Le Pavec J., Lorillon G., Jaïs X., et al. Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies. Chest: 2012; 142 5 1150 1157
73. Vassallo R., Ryu J. H., Schroeder D. R., Decker P. A., Limper A. H. Clinical outcomes of pulmonary Langerhans-cell histiocytosis in adults. N Engl J Med: 2002; 346 7 484 490